Dr. Martens plc (LON:DOCS – Get Free Report)’s share price was up 14.9% during mid-day trading on Thursday after the company announced a dividend. The company traded as high as GBX 70 ($0.89) and last traded at GBX 66.40 ($0.84). Approximately 9,112,005 shares traded hands during mid-day trading, an increase of 328% from the average daily volume of 2,131,099 shares. The stock had previously closed at GBX 57.80 ($0.73).
The newly announced dividend which will be paid on Tuesday, April 8th. Investors of record on Thursday, March 6th will be given a dividend of GBX 0.85 ($0.01) per share. This represents a yield of 1.47%. The ex-dividend date of this dividend is Thursday, March 6th. Dr. Martens’s dividend payout ratio is 4,285.71%.
Dr. Martens Price Performance
The business has a 50-day moving average of GBX 55.99 and a two-hundred day moving average of GBX 68.45. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 129.55. The firm has a market cap of £632.33 million, a P/E ratio of 825.71, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11.
Insider Buying and Selling
Dr. Martens Company Profile
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than Dr. Martens
- Consumer Discretionary Stocks Explained
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What to Know About Investing in Penny Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Why Invest in High-Yield Dividend Stocks?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.